Jonathan L. Koff

5.5k total citations · 1 hit paper
49 papers, 2.8k citations indexed

About

Jonathan L. Koff is a scholar working on Pulmonary and Respiratory Medicine, Ecology and Epidemiology. According to data from OpenAlex, Jonathan L. Koff has authored 49 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 14 papers in Ecology and 11 papers in Epidemiology. Recurrent topics in Jonathan L. Koff's work include Bacteriophages and microbial interactions (14 papers), Cystic Fibrosis Research Advances (12 papers) and Respiratory viral infections research (8 papers). Jonathan L. Koff is often cited by papers focused on Bacteriophages and microbial interactions (14 papers), Cystic Fibrosis Research Advances (12 papers) and Respiratory viral infections research (8 papers). Jonathan L. Koff collaborates with scholars based in United States, Germany and Japan. Jonathan L. Koff's co-authors include Benjamin K. Chan, Paul E. Turner, Kaitlyn E. Kortright, Jay A. Nadel, Iris F. Ueki, Matt X. G. Shao, Alastair G. Stewart, Belinda J. Thomas, Naftali Kaminski and Candice A. Smith and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Jonathan L. Koff

46 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phage Therapy: A Renewed Approach to Combat Antibiotic-Resistant Bacteria

2019 777 citations Kaitlyn E. Kortright, Benjamin K. Chan et al. Cell Host & Microbe profile →

Peers

Countries citing papers authored by Jonathan L. Koff

Since Specialization

Citations

This map shows the geographic impact of Jonathan L. Koff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan L. Koff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan L. Koff more than expected).

Fields of papers citing papers by Jonathan L. Koff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan L. Koff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan L. Koff. The network helps show where Jonathan L. Koff may publish in the future.

Co-authorship network of co-authors of Jonathan L. Koff

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan L. Koff. A scholar is included among the top collaborators of Jonathan L. Koff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan L. Koff. Jonathan L. Koff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Particle size distribution of viable nebulized bacteriophage for the treatment of multi-drug resistant Pseudomonas aeruginosa 2024 ·Respiratory Medicine and Research ·(unknown), (unknown), Richard Feinn, (unknown), Paul E. Turner, (unknown), Jonathan L. Koff, Thomas S. Murray	2
2	Cystic Fibrosis Bacteriophage Study at Yale (CYPHY) 2024 ·(unknown), Christina Cochrane, Benjamin K. Chan, Kaitlyn E. Kortright, (unknown), Andrew Lee, Albert C. Vill, Ying Sun, (unknown), (unknown), Z.M. Harris, (unknown), Veronika Shabanova, Paul E. Turner, Jonathan L. Koff	3
3	Human iPSC-Based Model of COPD to Investigate Disease Mechanisms, Predict SARS-COV-2 Outcome, and Test Preventive Immunotherapy 2024 ·Stem Cells ·Rania Dagher, Aigul Moldobaeva, (unknown), (unknown), Mia Madel Alfajaro, Craig B. Wilen, Finn Hawkins, Xiaotao Qu, Chia-Chien Chiang, Yang Li, (unknown), Yasuhiro Ikeda, Charles O. Brown, Roland Kolbeck, Qin Ma, Mauricio Rojas, Jonathan L. Koff, (unknown)	2
4	Lytic bacteriophages induce the secretion of antiviral and proinflammatory cytokines from human respiratory epithelial cells 2024 ·PLoS Biology ·Paula F. Zamora, (unknown), Catherine R. Armbruster, (unknown), Daria Van Tyne, Paul E. Turner, Jonathan L. Koff, Jennifer M. Bomberger	11
5	41 CYstic Fibrosis bacterioPHage study at Yale (CYPHY) 2023 ·Journal of Cystic Fibrosis ·Benjamin K. Chan, Kaitlyn E. Kortright, (unknown), Christina Cochrane, Andrew Lee, Albert C. Vill, Yan Sun, (unknown), (unknown), Z.M. Harris, (unknown), Veronika Shabanova, P Turner, Jonathan L. Koff	1
6	A Novel Zinc (II) Porphyrin Is Synergistic with PEV2 Bacteriophage against Pseudomonas aeruginosa Infections 2023 ·Antibiotics ·(unknown), (unknown), Z.M. Harris, Ying Sun, Lokesh Sharma, Silvia Würstle, Buqu Hu, Gail Stanley, Govindarajan Rajagopalan, (unknown), Jonathan L. Koff, Jayne B. Robinson	2
7	COVID-19 bacteremic co-infection is a major risk factor for mortality, ICU admission, and mechanical ventilation 2023 ·Critical Care ·Michael J. Patton, Carlos J. Orihuela, Kevin S. Harrod, Mohammad Alfrad Nobel Bhuiyan, Paari Dominic, Christopher G. Kevil, Daniel Fort, Jean‐Louis Vincent, Maha Farhat, Jonathan L. Koff, Charitharth Vivek Lal, Anuj Gaggar, Robert P. Richter, Nathaniel Erdmann, Matthew Might, Amit Gaggar	50
8	IFN- γ is Protective in Cytokine Release Syndrome-associated Extrapulmonary Acute Lung Injury 2022 ·American Journal of Respiratory Cell and Molecular Biology ·Ying Sun, Buqu Hu, Gail Stanley, Z.M. Harris, Samir Gautam, Robert Homer, Jonathan L. Koff, Govindarajan Rajagopalan	10
9	Novel Approaches to Multidrug-Resistant Infections in Cystic Fibrosis 2022 ·Clinics in Chest Medicine ·Thomas S. Murray, Gail Stanley, Jonathan L. Koff	8
10	Multi-dimensional clinical phenotyping of a national cohort of adult cystic fibrosis patients 2020 ·Journal of Cystic Fibrosis ·Douglas Conrad, Joanne Billings, Charlotte C. Tenebäck, Jonathan L. Koff, Daniel Rosenbluth, Barbara Bailey, Raksha Jain	7
11	Bacteriophage Therapy Decreases Pseudomonas Aeruginosa Lung Inflammation 2020 ·(unknown), Benjamin K. Chan, Isabel M. Ott, (unknown), Z.M. Harris, Ying Sun, Bo Hu, Govindarajan Rajagopalan, Paul E. Turner, Jonathan L. Koff	2
12	Metabolic Adaptation in Methicillin-Resistant Staphylococcus aureus Pneumonia 2019 ·American Journal of Respiratory Cell and Molecular Biology ·Stanislaw J. Gabryszewski, Tania Wong Fok Lung, Medini K. Annavajhala, Kira L. Tomlinson, Sebastián A. Riquelme, (unknown), Loreani P. Noguera, Matthew Wickersham, (unknown), (unknown), David R. Peaper, Jonathan L. Koff, Anne‐Catrin Uhlemann, Alice Prince	39
13	Phage Therapy: A Renewed Approach to Combat Antibiotic-Resistant Bacteria breakdown → 2019 ·Cell Host & Microbe ·Kaitlyn E. Kortright, Benjamin K. Chan, Jonathan L. Koff, Paul E. Turner	777
14	Respiratory syncytial virus activates epidermal growth factor receptor to suppress interferon regulatory factor 1-dependent interferon-lambda and antiviral defense in airway epithelium 2018 ·Mucosal Immunology ·April Kalinowski, Benjamin Galen, I. F. Ueki, Ying Sun, (unknown), Awo D. Osafo-Addo, Barbara J. Clark, (unknown), (unknown), Jay A. Nadel, Charles S. Dela Cruz, Jonathan L. Koff	65
15	DNA Repair Interacts with Autophagy To Regulate Inflammatory Responses to Pulmonary Hyperoxia 2017 ·The Journal of Immunology ·Yan Ye, Ping Lin, (unknown), Shirui Tan, Xikun Zhou, Rongpeng Li, Qinqin Pu, Jonathan L. Koff, Archana Dhasarathy, Feng Ma, Xin Deng, Jianxin Jiang, Min Wu	28
16	Pharmacological modulation of the AKT/microRNA-199a-5p/CAV1 pathway ameliorates cystic fibrosis lung hyper-inflammation 2015 ·Nature Communications ·Pingxia Zhang, Jijun Cheng, Siying Zou, Anthony D. D’Souza, Jonathan L. Koff, Jun Lü, Patty J. Lee, Diane S. Krause, Marie E. Egan, Emanuela M. Bruscia	85
17	Amphiregulin, an Epidermal Growth Factor Receptor Ligand, Plays an Essential Role in the Pathogenesis of Transforming Growth Factor-β-induced Pulmonary Fibrosis 2012 ·Journal of Biological Chemistry ·Yang Zhou, Jae‐Young Lee, Chang-Min Lee, Won‐Kyung Cho, Min‐Jong Kang, Jonathan L. Koff, (unknown), Jeiwook Chae, Han-Oh Park, Jack A. Elias, Chun Geun Lee	123
18	The Impact of Pretransplant Mechanical Ventilation on Short- and Long-Term Survival After Lung Transplantation 2011 ·American Journal of Transplantation ·(unknown), P.D. Blanc, Charles W. Hoopes, Jeffrey A. Golden, Jonathan L. Koff, Lorriana E. Leard, Sen Cheng, (unknown)	49
19	Airway Microbiota and Pathogen Abundance in Age-Stratified Cystic Fibrosis Patients 2010 ·PLoS ONE ·Michael J. Cox, Martin Allgaier, (unknown), Marshall Baek, Yvonne J. Huang, Rebecca A. Daly, Ulaş Karaöz, Gary L. Andersen, Ronald C. Brown, Kei E. Fujimura, (unknown), Diem Tran, Jonathan L. Koff, Mary Ellen Kleinhenz, Dennis W. Nielson, Eoin Brodie, Susan V. Lynch	339
20	Pseudomonas Lipopolysaccharide Accelerates Wound Repair via Activation of a Novel Epithelial Cell Signaling Cascade 2006 ·The Journal of Immunology ·Jonathan L. Koff, Matt X. G. Shao, Suil Kim, Iris F. Ueki, Jay A. Nadel	96

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact